《滬深兩市》憧憬放水上證全日近高收 深成創板升1.4%至2.6% 汽車股走高
內地昨日(11日)新增本土確診病例166例。人行今日(12日)進行100億人民幣(下同)7天期逆回購操作,利率持平。人民幣兌美元中間價今上調26點。內地上月CPI升1.5%低於預期,憧憬內地短期或放水,上證深成高開後表現向好,上證挨近3,600點收市,創板升幅明顯一度升3%。滬深兩市成交額連續第九個交易日破萬億元。
上證高見3,599,全日升29點或0.8%,近全日高位收報3,597點;深成指升197點或1.4%,收報14,421點;滬深300指數升47點或1%,收報4,845點;創業板指數升80點或2.6%,近高位收報3,136點,成交2,460億元。上證深成全日成交分別爲4,358億元及6,253億元。
中資金融股偏軟,工行(601398.SH)及建行(601939.SH)分別跌0.6%及1%。國壽(601628.SH)亦跌0.2%。
部分內房股走弱,世茂股份(600823.SH)、大龍地產(600159.SH)及招商蛇口(001979.SZ)跌2.3%至3.9%。上實發展(600748.SH)控股子公司應收類賬款或存在不可收回風險,股價跌5.2%。
汽車股走高,長汽(601633.SH)、比亞迪(002594.SZ)、廣汽(601238.SH)升4.6%至7.1%。
中藥股個別發展,東阿阿膠(000423.SZ)挫9.2%。紅日藥業(300026.SZ)升4.4%。疫苗股持續造好,九安醫療(002432.SZ)、博拓生物(688767.SH)漲停。
寧德時代(300750.SZ)升5.3%。貴州茅臺(600519.SH)升1.4%。
包鋼股份(600010.SH)料去年淨利潤按年增五倍至八倍,股價跌4.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.